Yuyu Pharma, Inc. 000220

Robert Wonsang Yu, CEO of Yuyu Pharma, has launched "Robert's YUniverse", a new podcast series featuring conversations with guests from across culture, business and animal health.

Ari's Purrfect Omega+Multivitamin Lickable Supplement expands the Feline First product line as Yuyu Pharma's U.S. pet subsidiary approaches a full year of growth at Magnify on UCLA campus.

Mervyn's Petcare, the U.S. subsidiary of Korea-based Yuyu Pharmaceutical (KRX: 000220), has launched its first cat dental care nutritional supplement product, "Ari's Purrfect Dental Bites," on Amazon. This launch marks the company's initial foray into the U.S. pet health market and a significant milestone in its global expansion strategy.

Yuyu Pharma announced today that it has completed a strategic investment in Dalan Animal Health, a U.S.-based biotechnology company advancing an innate immunity–based platform for developing vaccines for honeybees and shrimp. The investment marks a significant step in Yuyu Pharma's plan to become a more active global player in the fast-growing animal health sector.